Compare BNR & NLOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BNR | NLOP |
|---|---|---|
| Founded | 2014 | N/A |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 179.7M | 194.2M |
| IPO Year | 2019 | 2022 |
| Metric | BNR | NLOP |
|---|---|---|
| Price | $15.00 | $11.83 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 12.6K | ★ 152.5K |
| Earning Date | 06-05-2026 | 05-19-2026 |
| Dividend Yield | N/A | ★ 52.20% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.69 |
| Revenue | N/A | ★ $118,915,000.00 |
| Revenue This Year | $111.65 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $7.03 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.80 | $11.24 |
| 52 Week High | $41.72 | $34.53 |
| Indicator | BNR | NLOP |
|---|---|---|
| Relative Strength Index (RSI) | 34.47 | 41.98 |
| Support Level | $7.99 | $11.24 |
| Resistance Level | $22.50 | $13.50 |
| Average True Range (ATR) | 0.88 | 0.41 |
| MACD | -0.10 | -0.03 |
| Stochastic Oscillator | 1.67 | 26.60 |
Burning Rock Biotech Ltd is a cancer diagnostics company. The Group provides pharma research and development services, mainly cancer therapy selection tests services, companion diagnostics development services, and other service agreements with the combination of various customized tests services and analytical validation services, to pharmaceutical companies for developing new drugs for targeted therapies, immunotherapies on various types of cancers, and to hospitals for their studies on cancer diagnosis & treatment. It had three operating segments, including the Central laboratory business, the In-hospital business, & Pharma research & development services. It generates the majority of its revenue from the Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, & others.
Net Lease Office Properties is a Maryland real estate investment trust that, together with its consolidated subsidiaries, owns, operates, and finances a diversified portfolio of office properties mainly leased to corporate tenants on a single-tenant, net-lease basis. The company operates as a single operating and reportable segment focused on owning and managing office properties that generate revenue mainly from long-term lease agreements with tenants.